Compare Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) vs Wheaton Precious Metals Corp — how do they compare? Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B), while Wheaton Precious Metals Corp trades at $138.27 (market cap $60.84B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) and Wheaton Precious Metals Corp are close in size by market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.36%). Which is the better fit depends on your goals — on Pluang, investors hold Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days and Wheaton Precious Metals Corp for 66 Days on average.
| TAK | WPM | |
|---|---|---|
Market Cap | $58.16B | $60.84B |
Volume | 2,467,530 | 1,408,370 |
Sector | Health | Basic Materials |
52-Week High | $19.05 | $165.72 |
52-Week Low | $13.23 | $94.37 |
Typical Hold Time | 0 Days | 66 Days |
Enterprise Value | $86.04B | $62.71B |
Dividend Yield | 3.36% | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Wheaton Precious Metals (WPM) trades at $134.96, down 1.95% on the day, amid a bearish technical signal. The company reported record revenues of $2.31B in 2025, with net income surging to $1.47B, and has beaten EPS estimates for three consecutive quarters. Recent news highlights a growth strategy targeting 1.2 million ounces of production by 2030 through an expanded deal pipeline, supported by a fully funded capital plan.
The outlook remains positive with strong analyst support—80% recommend Buy and a consensus price target of $164.80 implies 22% upside. Key risks include execution of growth targets and sensitivity to gold/silver prices. The stock's current valuation multiples are elevated, but robust cash flow and margin expansion underpin the bullish case for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
